Skip to content

Study on the use of baby sunscreen products in infants with atopic dermatitis

Study on the use of baby sunscreen products in infants with atopic dermatitis - Study on the use of baby sunscreen products in infants with atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051240
Enrollment
25
Registered
2023-06-02
Start date
2023-06-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infants from 2 months to under 6 years of age with mild to moderate atopic dermatitis.

Interventions

Sponsors

Medical Corporation Koujinkai Hiraoka Dermatology Skincare Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Persons with mild to moderate atopic dermatitis 2.Infants between 2 months and 6 years of age on the date of obtaining consent prior to the screening test 3.The person must have been fully informed of the purpose and content of the research and must have agreed in writing to participate freely and voluntarily in the research on behalf of the research subject

Exclusion criteria

Exclusion criteria: 1.Patients with rashes at the examination areas that intervene the evaluation 2.Patients with rosacea-like dermatitis or with steroid skin disease 3.Patients who take or anticipate to take medicines that affect the study such as oral steroids, immunosuppresant 4.Patients who have experienced severe skin symptoms many times due to the use of cosmetics in the past 5.Patients who are judged as inappropriate by principal investigator or sub-investigator with other reasons

Design outcomes

Primary

MeasureTime frame
Safety Assessment / Skin findings,Subjective symptoms and adverse events

Secondary

MeasureTime frame
validity assessment / Changes in skin findings and subjective symptoms

Countries

Japan

Contacts

Public ContactYuki Sato

Clinical Support Corporation Co., Ltd. R & D Headquarters Cosmetics Division

y-sato@csc-smo.co.jp011-223-3130

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026